Clinical Trials Directory

Trials / Completed

CompletedNCT04195061

Relative Sarcopenia and Cardiometabolic Risk in Young Adults With Obesity

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The goal of this research study is to learn more about the hormones that muscles make during exercise, and if those hormones are associated with type 2 diabetes risk in adults who are overweight or obese. Participants will undergo exercise testing on an upright bicycle, with blood samples taken for muscle hormones before and after exercise. The hypothesis is that adults with overweight/obesity and insulin resistance will have an impaired muscle hormone profile in response to exercise compared to adults with overweight/obesity who are not insulin resistant.

Conditions

Interventions

TypeNameDescription
PROCEDURECardiopulmonary exercise test (CPET)CPET studies will be performed in the Cardiovascular Performance Program exercise lab at MGH. Subjects will undergo CPET on an upright cycle ergometer with continual measurement of metabolic gas exchange via a commercially available metabolic cart as well as heart rate and blood pressure. Exercise will proceed according to a maximal effort clinical protocol. Subjects will then undergo a standardized 30-min work load on the upright cycle ergometer based on the results of the maximal effort clinical protocol.

Timeline

Start date
2019-12-12
Primary completion
2021-11-17
Completion
2021-11-17
First posted
2019-12-11
Last updated
2024-01-30
Results posted
2024-01-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04195061. Inclusion in this directory is not an endorsement.